Skip to main content
. 2011 Oct 17;60(11):2748–2757. doi: 10.2337/db11-0650

TABLE 2.

Comparisons of participants with low and high baseline serum 25(OH)D

Low serum 25(OH)D (case subjects, n = 105) High serum 25(OH)D (control subjects, n = 50) P value
Ln ISI 120–180 min (μmol ⋅ min−1 ⋅ kg−1/pmol−1 ⋅ L−1)
 Model 1 −2.27 (−2.39 to −2.16) −2.03 (−2.20 to −1.87) 0.02
 Model 2 −2.25 (−2.36 to −2.14) −2.08 (−2.25 to −1.92) 0.10
 Model 3 −2.25 (−2.37 to −2.13) −2.11 (−2.29 to −1.92)* 0.24
HbA1c (%)
 Model 1 5.56 (5.50 to 5.62) 5.36 (5.27 to 5.44) <0.01
 Model 2 5.56 (5.50 to 5.62) 5.35 (5.27 to 5.44) <0.01
 Model 3 5.57 (5.50 to 5.63) 5.33 (5.23 to 5.42)* <0.01
Ln TG (mmol/L)
 Model 1 0.050 (−0.040 to 0.140) −0.097 (−0.228 to 0.034) 0.07
 Model 2 0.046 (−0.043 to 0.135) −0.088 (−0.219 to 0.043) 0.10
 Model 3 0.054 (−0.042 to 0.150) −0.093 (−0.241 to 0.054)* 0.12
Ln TG (mmol/L)§
 Model 1 0.041 (−0.050 to 0.132) −0.140 (−0.278 to −0.003) 0.03
 Model 2 0.036 (−0.055 to 0.127) −0.129 (−0.267 to 0.008) 0.051
 Model 3 0.038 (−0.058 to 0.135) −0.123 (−0.278 to 0.031)* 0.10

Data are estimated means (95% CI), using general linear models. Model 1: means adjusted for age, sex, and BMI; model 2: model 1 plus leisure time physical activity; and model 3: model 2 plus fat fish intake, dairy servings per week, sun bed use, sunny holidays past 3 months, and vitamin D supplementation.

*Data missing in one participant.

†Data missing in two participants.

‡Data missing in four participants.

§Statin users excluded (five case subjects and six control subjects).